Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Yves Cahn

Showing results (101-110 of 168) with videos related to

Pageof 17
Sort By:
American Journal of Hematology|December 23, 2015
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment studyMichael Loschi, Raphael Porcher, Fiorenza Barraco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2018
Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO TrialArnaud Pigneux, Marie C Béné, Louis-Rachid Salmi, et al.
Blood|March 13, 2012
Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor eraErica Warlick, Kwang Woo Ahn, Tanya L Pedersen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2018
Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party StudyAnnalisa Paviglianiti, Karina Tozatto Maio, Vanderson Rocha, et al.
Bone Marrow Transplantation|January 30, 2021
Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMTSimone Cesaro, Gloria Tridello, Nina Simone Knelange, et al.
Blood|November 3, 2007
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA resultsLionel Adès, Miguel A Sanz, Sylvie Chevret, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic LeukemiaBrian T Hill, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Blood|April 16, 2011
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysisMukta Arora, John P Klein, Daniel J Weisdorf, et al.
Blood|September 1, 2011
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host diseaseDavid A Jacobsohn, Mukta Arora, John P Klein, et al.
Leukemia|September 18, 2020
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO studyLaetitia Largeaud, Pascale Cornillet-Lefebvre, Jean-François Hamel, et al.
Pageof 17

Showing results (101-110 of 168) with videos related to

Sort By:
Pageof 17
American Journal of Hematology|December 23, 2015
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment studyMichael Loschi, Raphael Porcher, Fiorenza Barraco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2018
Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO TrialArnaud Pigneux, Marie C Béné, Louis-Rachid Salmi, et al.
Blood|March 13, 2012
Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor eraErica Warlick, Kwang Woo Ahn, Tanya L Pedersen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2018
Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party StudyAnnalisa Paviglianiti, Karina Tozatto Maio, Vanderson Rocha, et al.
Bone Marrow Transplantation|January 30, 2021
Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMTSimone Cesaro, Gloria Tridello, Nina Simone Knelange, et al.
Blood|November 3, 2007
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA resultsLionel Adès, Miguel A Sanz, Sylvie Chevret, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic LeukemiaBrian T Hill, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Blood|April 16, 2011
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysisMukta Arora, John P Klein, Daniel J Weisdorf, et al.
Blood|September 1, 2011
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host diseaseDavid A Jacobsohn, Mukta Arora, John P Klein, et al.
Leukemia|September 18, 2020
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO studyLaetitia Largeaud, Pascale Cornillet-Lefebvre, Jean-François Hamel, et al.
Pageof 17